Kamada Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Kamada Ltd., a foreign private issuer, on August 4, 2015. The report covers the month of August 2015 and serves to disclose a material corporate governance event rather than financial performance data.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a board appointment and does not contain financial statements or operational metrics.
Material Changes
The primary material change disclosed in this filing is the appointment of Michael Berelowitz, M.D., to the Company's Board of Directors. No financial or operational changes were reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is limited to the announcement of the new board member.
Key Facts for Investor Verification
- Michael Berelowitz, M.D., has been appointed to the Board of Directors.
- The filing was signed by Gil Efron, Deputy Chief Executive and Chief Financial Officer.
- This Form 6-K is incorporated by reference into the Company's Form S-8 Registration Statement (File No. 333-192720).
- No financial data is included in this specific filing; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.